Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|June 8, 2002
Serine/threonine phosphorylation of ShcA. Regulation of protein-tyrosine phosphatase-pest binding and involvement in insulin signalingAmir Faisal, Mahmoud el-Shemerly, Daniel Hess, et al.
Cancer Research|May 4, 2005
Degradation of human exonuclease 1b upon DNA synthesis inhibitionMahmoud El-Shemerly, Pavel Janscak, Daniel Hess, et al.
Cell Cycle (Georgetown, Tex.)|July 12, 2007
Mismatch repair status and the response of human cells to cisplatinElisabetta Pani, Lovorka Stojic, Mahmoud El-Shemerly, et al.
Nucleic Acids Research|December 1, 2007
ATR-dependent pathways control hEXO1 stability in response to stalled forksMahmoud El-Shemerly, Daniel Hess, Aswin K Pyakurel, et al.
The Biochemical Journal|August 9, 2005
Aurora-A site specificity: a study with synthetic peptide substratesStefano Ferrari, Oriano Marin, Mario A Pagano, et al.
Anti-Cancer Drugs|February 2, 2023
Derazantinib, a fibroblast growth factor receptor inhibitor, inhibits colony-stimulating factor receptor-1 in macrophages and tumor cells and in combination with a murine programmed cell death ligand-1-antibody activates the immune environment of murine syngeneic tumor modelsMahmoud El Shemerly, Elisa Zanini, Marc Lecoultre, et al.
EMBO Reports|November 6, 2010
DNA end resection by CtIP and exonuclease 1 prevents genomic instabilityWassim Eid, Martin Steger, Mahmoud El-Shemerly, et al.
Anti-Cancer Drugs|February 2, 2023
The fibroblast growth factor receptor inhibitor, derazantinib, has strong efficacy in human gastric tumor models and synergizes with paclitaxel in vivoPaul M J McSheehy, Nicole Forster-Gross, Mahmoud El Shemerly, et al.
Anti-Cancer Drugs|June 19, 2025
Discovery and optimization of oxidative phosphorylation inhibitors from a phenotypic screenMahmoud El Shemerly, Florian Richalet, Dimitri Robay, et al.
Expert Opinion on Investigational Drugs|October 26, 2021
Derazantinib: an investigational drug for the treatment of cholangiocarcinomaStephan Braun, Paul McSheehy, Karine Litherland, et al.
Pageof 2